Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

NCT00296062 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Trial did not move to Phase II portion due to poor tolerance of treatment

Conditions

Colorectal Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: bevacizumab
DRUG: capecitabine
DRUG: irinotecan hydrochloride
DRUG: oxaliplatin

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]